Metabolys

Calculating rank

USPTO Granted Patents = 4

% Expired Patents = 50.0

EPO Patents = 3

Forward Citations = 3

Loading Chart...

4 inventors (with patents filed for the assignee):

Gabriel Baverel (4 out of 4 patents)

Gérard Moinet (4 out of 26 patents)

Remi Nazaret (2 out of 2 patents)

4. Bernard Ferrier (2 out of 2 patents)

5. Rémi Nazaret (0 patent)

4 patents: Sort by Forward Citations

1. 11324743 - Treatment for the non alcoholic steatohepatitis and fibrosis (2022-05-10),

2. 9545387 - Composition and kit comprising piperazine derivatives and metformin, and use thereof in the treatment of diabetes (2017-01-17),

3. 9150529 - Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance (2015-10-06),

4. 9150523 - Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance (2015-10-06),

Company Overview

Metabolys is a biotechnology company focused on developing new treatments for metabolic diseases. Our innovative research and development programs aim to address unmet medical needs in conditions such as obesity, diabetes, and cardiovascular diseases. We are committed to advancing scientific knowledge and improving patient outcomes through our cutting-edge therapeutic solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

4 Patents

#58 in Lyon

#3,357 in France

Lyon, France

Metabolys

Forward Citations = 3

4 inventors:

Gabriel Baverel (4 out of 4 patents)

Gérard Moinet (4 out of 26 patents)

Remi Nazaret (2 out of 2 patents)

4. Bernard Ferrier (2 out of 2 patents)

5. Rémi Nazaret (0 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Metabolys. Retrieved from https://idiyas.com/company/metabolys

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]